JP2014512331A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014512331A5 JP2014512331A5 JP2013545050A JP2013545050A JP2014512331A5 JP 2014512331 A5 JP2014512331 A5 JP 2014512331A5 JP 2013545050 A JP2013545050 A JP 2013545050A JP 2013545050 A JP2013545050 A JP 2013545050A JP 2014512331 A5 JP2014512331 A5 JP 2014512331A5
- Authority
- JP
- Japan
- Prior art keywords
- ingenol
- carboxylate
- alkyl
- methyl
- pharmaceutically acceptable
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 claims description 41
- 125000000592 heterocycloalkyl group Chemical group 0.000 claims description 39
- 229910003827 NRaRb Inorganic materials 0.000 claims description 38
- 125000001072 heteroaryl group Chemical group 0.000 claims description 38
- 125000003118 aryl group Chemical group 0.000 claims description 35
- 150000001875 compounds Chemical class 0.000 claims description 25
- 150000003839 salts Chemical class 0.000 claims description 24
- 239000012453 solvate Substances 0.000 claims description 24
- 229910052736 halogen Inorganic materials 0.000 claims description 23
- -1 cyano, hydroxy Chemical group 0.000 claims description 21
- 125000000753 cycloalkyl group Chemical group 0.000 claims description 20
- 125000001424 substituent group Chemical group 0.000 claims description 20
- 150000002367 halogens Chemical class 0.000 claims description 18
- 125000004399 C1-C4 alkenyl group Chemical group 0.000 claims description 16
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 15
- 125000006272 (C3-C7) cycloalkyl group Chemical group 0.000 claims description 14
- 125000004093 cyano group Chemical group *C#N 0.000 claims description 14
- 229910052739 hydrogen Inorganic materials 0.000 claims description 13
- 239000001257 hydrogen Substances 0.000 claims description 13
- 125000004366 heterocycloalkenyl group Chemical group 0.000 claims description 11
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 10
- 125000003710 aryl alkyl group Chemical group 0.000 claims description 8
- 125000005885 heterocycloalkylalkyl group Chemical group 0.000 claims description 8
- 125000000229 (C1-C4)alkoxy group Chemical group 0.000 claims description 5
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 3
- VEBVPUXQAPLADL-UHFFFAOYSA-N Ingenol Natural products C1=C(CO)C(O)C2(O)C(O)C(C)=CC32C(C)CC2C(C)(C)C2C1C3=O VEBVPUXQAPLADL-UHFFFAOYSA-N 0.000 claims 105
- VEBVPUXQAPLADL-POYOOMFHSA-N ingenol Chemical compound C1=C(CO)[C@@H](O)[C@]2(O)[C@@H](O)C(C)=C[C@]32[C@H](C)C[C@H]2C(C)(C)[C@H]2[C@H]1C3=O VEBVPUXQAPLADL-POYOOMFHSA-N 0.000 claims 105
- 239000003814 drug Substances 0.000 claims 5
- 125000005843 halogen group Chemical group 0.000 claims 5
- 206010004146 Basal cell carcinoma Diseases 0.000 claims 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 4
- 206010041823 squamous cell carcinoma Diseases 0.000 claims 4
- VVICVFRJARFOHY-UHFFFAOYSA-N 2-(trifluoromethyl)pyrrolidine-1-carboxylic acid Chemical compound OC(=O)N1CCCC1C(F)(F)F VVICVFRJARFOHY-UHFFFAOYSA-N 0.000 claims 3
- 206010028980 Neoplasm Diseases 0.000 claims 3
- 238000004519 manufacturing process Methods 0.000 claims 3
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 3
- 239000008194 pharmaceutical composition Substances 0.000 claims 3
- GLIUZQUNUNICGS-XUBYYPQFSA-N 3b100vj4zw Chemical compound CCC1=NOC(CC)=C1C(=O)O[C@@H]1[C@@]2(O)[C@H](O)C(CO)=C[C@H](C3=O)[C@H](C4(C)C)[C@H]4C[C@@H](C)[C@]23C=C1C GLIUZQUNUNICGS-XUBYYPQFSA-N 0.000 claims 2
- 206010051999 Anogenital dysplasia Diseases 0.000 claims 2
- 206010059313 Anogenital warts Diseases 0.000 claims 2
- 206010008263 Cervical dysplasia Diseases 0.000 claims 2
- 208000000907 Condylomata Acuminata Diseases 0.000 claims 2
- 208000009608 Papillomavirus Infections Diseases 0.000 claims 2
- 206010054932 Vulvar dysplasia Diseases 0.000 claims 2
- 208000018777 Vulvar intraepithelial neoplasia Diseases 0.000 claims 2
- 208000000260 Warts Diseases 0.000 claims 2
- 208000009621 actinic keratosis Diseases 0.000 claims 2
- 201000011510 cancer Diseases 0.000 claims 2
- 208000007951 cervical intraepithelial neoplasia Diseases 0.000 claims 2
- 229910052801 chlorine Inorganic materials 0.000 claims 2
- 239000002537 cosmetic Substances 0.000 claims 2
- 201000010099 disease Diseases 0.000 claims 2
- 208000035475 disorder Diseases 0.000 claims 2
- 206010020718 hyperplasia Diseases 0.000 claims 2
- 230000003902 lesion Effects 0.000 claims 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 2
- 208000017520 skin disease Diseases 0.000 claims 2
- 201000010153 skin papilloma Diseases 0.000 claims 2
- 125000000335 thiazolyl group Chemical group 0.000 claims 2
- 125000001399 1,2,3-triazolyl group Chemical group N1N=NC(=C1)* 0.000 claims 1
- MIKOZAZRIJWWRE-UHFFFAOYSA-N 1,2,4-trimethylpyrrole-3-carboxylic acid Chemical compound CC1=CN(C)C(C)=C1C(O)=O MIKOZAZRIJWWRE-UHFFFAOYSA-N 0.000 claims 1
- JTEBLTWGSAXWEE-UHFFFAOYSA-N 1,2,5-trimethylpyrrole-3-carboxylic acid Chemical compound CC1=CC(C(O)=O)=C(C)N1C JTEBLTWGSAXWEE-UHFFFAOYSA-N 0.000 claims 1
- VPYXATIIMHQAPR-UHFFFAOYSA-N 1,2-benzoxazole-3-carboxylic acid Chemical compound C1=CC=C2C(C(=O)O)=NOC2=C1 VPYXATIIMHQAPR-UHFFFAOYSA-N 0.000 claims 1
- XYRXQPDMBJNYIU-UHFFFAOYSA-N 1,2-dimethylindole-3-carboxylic acid Chemical compound C1=CC=C2N(C)C(C)=C(C(O)=O)C2=C1 XYRXQPDMBJNYIU-UHFFFAOYSA-N 0.000 claims 1
- NOIOGQJFLIPRBI-UHFFFAOYSA-N 1,3,5-trimethylpyrazole-4-carboxylic acid Chemical compound CC1=NN(C)C(C)=C1C(O)=O NOIOGQJFLIPRBI-UHFFFAOYSA-N 0.000 claims 1
- UUYNZCLYPLJBTG-UHFFFAOYSA-N 1,3,5-trimethylpyrrole-2-carboxylic acid Chemical compound CC=1C=C(C)N(C)C=1C(O)=O UUYNZCLYPLJBTG-UHFFFAOYSA-N 0.000 claims 1
- ZPPXWZDJDIOJFP-UHFFFAOYSA-N 1,3-dihydroisoindole-2-carboxylic acid Chemical compound C1=CC=C2CN(C(=O)O)CC2=C1 ZPPXWZDJDIOJFP-UHFFFAOYSA-N 0.000 claims 1
- GUAVXCSZSKSTBL-UHFFFAOYSA-N 1,3-dimethylindole-2-carboxylic acid Chemical compound C1=CC=C2C(C)=C(C(O)=O)N(C)C2=C1 GUAVXCSZSKSTBL-UHFFFAOYSA-N 0.000 claims 1
- SIZRIGSBZPWTOL-UHFFFAOYSA-N 1,3-dimethylpyrrole-2-carboxylic acid Chemical compound CC=1C=CN(C)C=1C(O)=O SIZRIGSBZPWTOL-UHFFFAOYSA-N 0.000 claims 1
- DYGGJXVTZCRGTE-UHFFFAOYSA-N 1,5-dimethyl-3-phenylpyrazole-4-carboxylic acid Chemical compound CN1C(C)=C(C(O)=O)C(C=2C=CC=CC=2)=N1 DYGGJXVTZCRGTE-UHFFFAOYSA-N 0.000 claims 1
- NDJXNNQYGYBVNQ-UHFFFAOYSA-N 1,5-dimethylpyrrole-2-carboxylic acid Chemical compound CC1=CC=C(C(O)=O)N1C NDJXNNQYGYBVNQ-UHFFFAOYSA-N 0.000 claims 1
- VPQDTFDJFQLUQA-UHFFFAOYSA-N 1-(2-methoxyethyl)-2,4-dimethylpyrrole-3-carboxylic acid Chemical compound COCCN1C=C(C)C(C(O)=O)=C1C VPQDTFDJFQLUQA-UHFFFAOYSA-N 0.000 claims 1
- OWECYPGUAPISSL-UHFFFAOYSA-N 1-(cyclopropylmethyl)-2,4-dimethylpyrrole-3-carboxylic acid Chemical compound CC1=C(C(O)=O)C(C)=CN1CC1CC1 OWECYPGUAPISSL-UHFFFAOYSA-N 0.000 claims 1
- QBQWUFSHKRRJPB-UHFFFAOYSA-N 1-benzyl-3,5-dimethylpyrazole-4-carboxylic acid Chemical compound CC1=C(C(O)=O)C(C)=NN1CC1=CC=CC=C1 QBQWUFSHKRRJPB-UHFFFAOYSA-N 0.000 claims 1
- VOOZJPFNBFNPEK-UHFFFAOYSA-N 1-cyclopropyl-2,5-dimethylpyrrole-3-carboxylic acid Chemical compound CC1=CC(C(O)=O)=C(C)N1C1CC1 VOOZJPFNBFNPEK-UHFFFAOYSA-N 0.000 claims 1
- VDFAGHFIPYSSIU-UHFFFAOYSA-N 1-cyclopropylpyrrole-2-carboxylic acid Chemical compound OC(=O)C1=CC=CN1C1CC1 VDFAGHFIPYSSIU-UHFFFAOYSA-N 0.000 claims 1
- CDCPECFYUDCGAB-UHFFFAOYSA-N 1-ethyl-2,4-dimethylpyrrole-3-carboxylic acid Chemical compound CCN1C=C(C)C(C(O)=O)=C1C CDCPECFYUDCGAB-UHFFFAOYSA-N 0.000 claims 1
- JRMRPWSXOZSUAM-UHFFFAOYSA-N 1-ethyl-3,5-dimethylpyrrole-2-carboxylic acid Chemical compound CCN1C(C)=CC(C)=C1C(O)=O JRMRPWSXOZSUAM-UHFFFAOYSA-N 0.000 claims 1
- ZPUSQIWNVXTSPW-UHFFFAOYSA-N 1-methyl-3-phenylindole-2-carboxylic acid Chemical compound C12=CC=CC=C2N(C)C(C(O)=O)=C1C1=CC=CC=C1 ZPUSQIWNVXTSPW-UHFFFAOYSA-N 0.000 claims 1
- OVVDFORZEGKEJM-UHFFFAOYSA-M 1-methylindazole-3-carboxylate Chemical compound C1=CC=C2N(C)N=C(C([O-])=O)C2=C1 OVVDFORZEGKEJM-UHFFFAOYSA-M 0.000 claims 1
- HVRCLXXJIQTXHC-UHFFFAOYSA-M 1-methylindole-3-carboxylate Chemical compound C1=CC=C2N(C)C=C(C([O-])=O)C2=C1 HVRCLXXJIQTXHC-UHFFFAOYSA-M 0.000 claims 1
- ILAOVOOZLVGAJF-UHFFFAOYSA-N 1-methylpyrrole-2-carboxylic acid Chemical compound CN1C=CC=C1C(O)=O ILAOVOOZLVGAJF-UHFFFAOYSA-N 0.000 claims 1
- UORJTRNJVITXTP-UHFFFAOYSA-N 1-tert-butyl-3,5-dimethylpyrazole-4-carboxylic acid Chemical compound CC1=NN(C(C)(C)C)C(C)=C1C(O)=O UORJTRNJVITXTP-UHFFFAOYSA-N 0.000 claims 1
- IPDOBVFESNNYEE-UHFFFAOYSA-M 1h-indole-7-carboxylate Chemical compound [O-]C(=O)C1=CC=CC2=C1NC=C2 IPDOBVFESNNYEE-UHFFFAOYSA-M 0.000 claims 1
- SYWUPYPWAYRZDQ-UHFFFAOYSA-N 2,3-dihydro-1,4-benzoxazine-4-carboxylic acid Chemical compound C1=CC=C2N(C(=O)O)CCOC2=C1 SYWUPYPWAYRZDQ-UHFFFAOYSA-N 0.000 claims 1
- TYHYESDUJZRBKS-UHFFFAOYSA-N 2,3-dihydroindole-1-carboxylic acid Chemical compound C1=CC=C2N(C(=O)O)CCC2=C1 TYHYESDUJZRBKS-UHFFFAOYSA-N 0.000 claims 1
- BAZBYDHOWMSZBD-UHFFFAOYSA-N 2,4,5-trimethylfuran-3-carboxylic acid Chemical compound CC=1OC(C)=C(C(O)=O)C=1C BAZBYDHOWMSZBD-UHFFFAOYSA-N 0.000 claims 1
- MQGBARXPCXAFRZ-UHFFFAOYSA-N 2,4-dimethyl-1,3-thiazole-5-carboxylic acid Chemical compound CC1=NC(C)=C(C(O)=O)S1 MQGBARXPCXAFRZ-UHFFFAOYSA-N 0.000 claims 1
- XBPJVSRTTKVMEN-UHFFFAOYSA-M 2,4-dimethyl-1h-pyrrole-3-carboxylate Chemical compound CC1=CNC(C)=C1C([O-])=O XBPJVSRTTKVMEN-UHFFFAOYSA-M 0.000 claims 1
- LHGRUGVXZLHYKE-UHFFFAOYSA-N 2,5-dimethyl-1,3-oxazole-4-carboxylic acid Chemical compound CC1=NC(C(O)=O)=C(C)O1 LHGRUGVXZLHYKE-UHFFFAOYSA-N 0.000 claims 1
- JBGWUKMKNIMSOU-UHFFFAOYSA-N 2-chloro-5-propan-2-yl-1,3-thiazole-4-carboxylic acid Chemical compound CC(C)C=1SC(Cl)=NC=1C(O)=O JBGWUKMKNIMSOU-UHFFFAOYSA-N 0.000 claims 1
- NNMGTKSNBXYSER-UHFFFAOYSA-N 2-methoxy-4-methyl-1,3-thiazole-5-carboxylic acid Chemical compound COC1=NC(C)=C(C(O)=O)S1 NNMGTKSNBXYSER-UHFFFAOYSA-N 0.000 claims 1
- JPFHYMMFZMXFMY-UHFFFAOYSA-M 2-methyl-4,5,6,7-tetrahydroindazole-3-carboxylate Chemical compound C1CCCC2=C(C([O-])=O)N(C)N=C21 JPFHYMMFZMXFMY-UHFFFAOYSA-M 0.000 claims 1
- GOEZJIAQSROMFY-UHFFFAOYSA-N 2-methyl-4-(2-methylphenyl)pyrazole-3-carboxylic acid Chemical compound CC1=CC=CC=C1C1=C(C(O)=O)N(C)N=C1 GOEZJIAQSROMFY-UHFFFAOYSA-N 0.000 claims 1
- BNJPPGUQUVZCBA-UHFFFAOYSA-N 2-methyl-4-phenylpyrazole-3-carboxylic acid Chemical compound CN1N=CC(C=2C=CC=CC=2)=C1C(O)=O BNJPPGUQUVZCBA-UHFFFAOYSA-N 0.000 claims 1
- FBIUGCLQMKPURJ-UHFFFAOYSA-M 2-methylimidazo[1,2-a]pyridine-3-carboxylate Chemical compound C1=CC=CN2C(C([O-])=O)=C(C)N=C21 FBIUGCLQMKPURJ-UHFFFAOYSA-M 0.000 claims 1
- ABRISPFTOZIXMP-UHFFFAOYSA-N 2-methylindazole-3-carboxylic acid Chemical compound C1=CC=CC2=C(C(O)=O)N(C)N=C21 ABRISPFTOZIXMP-UHFFFAOYSA-N 0.000 claims 1
- FLYDUXCFCARXHI-UHFFFAOYSA-N 2-phenylpyrazole-3-carboxylic acid Chemical compound OC(=O)C1=CC=NN1C1=CC=CC=C1 FLYDUXCFCARXHI-UHFFFAOYSA-N 0.000 claims 1
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 claims 1
- JZPMLZWJUMATOQ-UHFFFAOYSA-N 2-tert-butyl-5-methylpyrazole-3-carboxylic acid Chemical compound CC=1C=C(C(O)=O)N(C(C)(C)C)N=1 JZPMLZWJUMATOQ-UHFFFAOYSA-N 0.000 claims 1
- FVTWJYOGVFLUNJ-UHFFFAOYSA-N 3,3-dimethyl-1-[(2-methylpropan-2-yl)oxycarbonyl]pyrrolidine-2-carboxylic acid Chemical compound CC(C)(C)OC(=O)N1CCC(C)(C)C1C(O)=O FVTWJYOGVFLUNJ-UHFFFAOYSA-N 0.000 claims 1
- YIEADNILIRHBHR-UHFFFAOYSA-N 3,3-dimethylpiperidine-1-carboxylic acid Chemical compound CC1(C)CCCN(C(O)=O)C1 YIEADNILIRHBHR-UHFFFAOYSA-N 0.000 claims 1
- ZLUUPCCXIKTEBG-UHFFFAOYSA-N 3,4-dihydro-2h-quinoline-1-carboxylic acid Chemical compound C1=CC=C2N(C(=O)O)CCCC2=C1 ZLUUPCCXIKTEBG-UHFFFAOYSA-N 0.000 claims 1
- KTRDIIZBYGBKTO-UHFFFAOYSA-N 3,4-dihydro-2h-quinoxaline-1-carboxylic acid Chemical compound C1=CC=C2N(C(=O)O)CCNC2=C1 KTRDIIZBYGBKTO-UHFFFAOYSA-N 0.000 claims 1
- IJEUISLJVBUNRE-UHFFFAOYSA-N 3,5-dimethyl-1,2-oxazole-4-carboxylic acid Chemical compound CC1=NOC(C)=C1C(O)=O IJEUISLJVBUNRE-UHFFFAOYSA-N 0.000 claims 1
- QFUYZERHMQJGCA-UHFFFAOYSA-N 3,5-dimethyl-1,2-thiazole-4-carboxylic acid Chemical compound CC1=NSC(C)=C1C(O)=O QFUYZERHMQJGCA-UHFFFAOYSA-N 0.000 claims 1
- LPYTYYLNGJGJGW-UHFFFAOYSA-N 3,5-dimethyl-1-phenylpyrazole-4-carboxylic acid Chemical compound CC1=C(C(O)=O)C(C)=NN1C1=CC=CC=C1 LPYTYYLNGJGJGW-UHFFFAOYSA-N 0.000 claims 1
- YLPYLNUXWGDQAG-UHFFFAOYSA-N 3,5-dimethyl-1-propan-2-ylpyrazole-4-carboxylic acid Chemical compound CC(C)N1N=C(C)C(C(O)=O)=C1C YLPYLNUXWGDQAG-UHFFFAOYSA-N 0.000 claims 1
- REIPZLFZMOQHJT-UHFFFAOYSA-N 3-(2-chloro-6-fluorophenyl)-5-methyl-1,2-oxazole-4-carboxylic acid Chemical compound OC(=O)C1=C(C)ON=C1C1=C(F)C=CC=C1Cl REIPZLFZMOQHJT-UHFFFAOYSA-N 0.000 claims 1
- KOQSJBSGCNLIJY-UHFFFAOYSA-N 3-(2-methoxyphenyl)-5-methyl-1,2-oxazole-4-carboxylic acid Chemical compound COC1=CC=CC=C1C1=NOC(C)=C1C(O)=O KOQSJBSGCNLIJY-UHFFFAOYSA-N 0.000 claims 1
- UXANYOUSBMHKBA-UHFFFAOYSA-N 3-azabicyclo[3.2.2]nonane-3-carboxylic acid Chemical compound C1N(C(=O)O)CC2CCC1CC2 UXANYOUSBMHKBA-UHFFFAOYSA-N 0.000 claims 1
- KBDIRPOTVAODSA-UHFFFAOYSA-M 3-bromopyridine-2-carboxylate Chemical compound [O-]C(=O)C1=NC=CC=C1Br KBDIRPOTVAODSA-UHFFFAOYSA-M 0.000 claims 1
- RSWFHHWVFZWIMV-UHFFFAOYSA-N 3-ethyl-5-methyl-1,2-oxazole-4-carboxylic acid Chemical compound CCC1=NOC(C)=C1C(O)=O RSWFHHWVFZWIMV-UHFFFAOYSA-N 0.000 claims 1
- YIVHOQIKHMTVRG-UHFFFAOYSA-N 3-methyl-1h-pyrrole-2-carboxylic acid Chemical compound CC=1C=CNC=1C(O)=O YIVHOQIKHMTVRG-UHFFFAOYSA-N 0.000 claims 1
- JDUCBQRNGOSNDG-UHFFFAOYSA-N 3-methyl-2,3-dihydro-1,4-benzoxazine-4-carboxylic acid Chemical compound CC1COC2=CC=CC=C2N1C(=O)O JDUCBQRNGOSNDG-UHFFFAOYSA-N 0.000 claims 1
- RLAVEODUCXLMQJ-UHFFFAOYSA-N 3-methyl-2-oxo-1-oxaspiro[4.5]dec-3-ene-4-carboxylic acid Chemical compound O1C(=O)C(C)=C(C(O)=O)C11CCCCC1 RLAVEODUCXLMQJ-UHFFFAOYSA-N 0.000 claims 1
- IFLKEBSJTZGCJG-UHFFFAOYSA-M 3-methylthiophene-2-carboxylate Chemical compound CC=1C=CSC=1C([O-])=O IFLKEBSJTZGCJG-UHFFFAOYSA-M 0.000 claims 1
- HHTIPFPDSPKHSV-UHFFFAOYSA-N 3-oxo-2,4-dihydroquinoxaline-1-carboxylic acid Chemical compound O=C1CN(C2=CC=CC=C2N1)C(=O)O HHTIPFPDSPKHSV-UHFFFAOYSA-N 0.000 claims 1
- FSVMTMFHLLEQAS-UHFFFAOYSA-N 3-phenylimidazole-4-carboxylic acid Chemical compound OC(=O)C1=CN=CN1C1=CC=CC=C1 FSVMTMFHLLEQAS-UHFFFAOYSA-N 0.000 claims 1
- KWWGBNRBZMJKPA-UHFFFAOYSA-N 3-phenylthiophene-2-carboxylic acid Chemical compound S1C=CC(C=2C=CC=CC=2)=C1C(=O)O KWWGBNRBZMJKPA-UHFFFAOYSA-N 0.000 claims 1
- WGNBQRMKJSODLB-UHFFFAOYSA-N 3-phenyltriazole-4-carboxylic acid Chemical compound OC(=O)C1=CN=NN1C1=CC=CC=C1 WGNBQRMKJSODLB-UHFFFAOYSA-N 0.000 claims 1
- UKBDFVBVJCUFQV-UHFFFAOYSA-N 3-tert-butyl-5-methyl-1,2-oxazole-4-carboxylic acid Chemical compound CC=1ON=C(C(C)(C)C)C=1C(O)=O UKBDFVBVJCUFQV-UHFFFAOYSA-N 0.000 claims 1
- KLPASEZGNSBTBD-UHFFFAOYSA-N 4,5-dimethyl-1,2-oxazole-3-carboxylic acid Chemical compound CC=1ON=C(C(O)=O)C=1C KLPASEZGNSBTBD-UHFFFAOYSA-N 0.000 claims 1
- BAWHTKAHVSSEGC-UHFFFAOYSA-N 4-(4-methoxyphenyl)-2-methylpyrazole-3-carboxylic acid Chemical compound C1=CC(OC)=CC=C1C1=C(C(O)=O)N(C)N=C1 BAWHTKAHVSSEGC-UHFFFAOYSA-N 0.000 claims 1
- LEEPGDCCHVRYHK-UHFFFAOYSA-M 4-bromo-1-methylpyrazole-3-carboxylate Chemical compound CN1C=C(Br)C(C([O-])=O)=N1 LEEPGDCCHVRYHK-UHFFFAOYSA-M 0.000 claims 1
- QBZXHFRMFOYDSR-UHFFFAOYSA-N 4-bromo-2-ethylpyrazole-3-carboxylic acid Chemical compound CCN1N=CC(Br)=C1C(O)=O QBZXHFRMFOYDSR-UHFFFAOYSA-N 0.000 claims 1
- YXIJCAVZGBGUKM-UHFFFAOYSA-N 4-bromo-2-methylpyrazole-3-carboxylic acid Chemical compound CN1N=CC(Br)=C1C(O)=O YXIJCAVZGBGUKM-UHFFFAOYSA-N 0.000 claims 1
- BZFXEYAWDBWTSY-UHFFFAOYSA-N 4-chloro-1-methylpyrazole-3-carboxylic acid Chemical compound CN1C=C(Cl)C(C(O)=O)=N1 BZFXEYAWDBWTSY-UHFFFAOYSA-N 0.000 claims 1
- BSCNPVBDEITWDU-UHFFFAOYSA-N 4-chloro-2,5-dimethylpyrazole-3-carboxylic acid Chemical compound CC1=NN(C)C(C(O)=O)=C1Cl BSCNPVBDEITWDU-UHFFFAOYSA-N 0.000 claims 1
- SOCMTMNWGCJGLA-UHFFFAOYSA-N 4-chloro-2-methylpyrazole-3-carboxylic acid Chemical compound CN1N=CC(Cl)=C1C(O)=O SOCMTMNWGCJGLA-UHFFFAOYSA-N 0.000 claims 1
- GAIAHHRZVGJYQW-UHFFFAOYSA-N 4-methyl-1,2,5-oxadiazole-3-carboxylic acid Chemical compound CC1=NON=C1C(O)=O GAIAHHRZVGJYQW-UHFFFAOYSA-N 0.000 claims 1
- YXYAHRAFINYJPL-UHFFFAOYSA-N 4-methyl-1h-pyrrole-2-carboxylic acid Chemical compound CC1=CNC(C(O)=O)=C1 YXYAHRAFINYJPL-UHFFFAOYSA-N 0.000 claims 1
- NVHAAIMFHOSMHD-UHFFFAOYSA-N 4-methyl-2-oxo-3h-1,3-thiazole-5-carboxylic acid Chemical compound CC=1NC(=O)SC=1C(O)=O NVHAAIMFHOSMHD-UHFFFAOYSA-N 0.000 claims 1
- HZZBITVSVYFOND-UHFFFAOYSA-N 5-bromopyrimidine-4-carboxylic acid Chemical compound OC(=O)C1=NC=NC=C1Br HZZBITVSVYFOND-UHFFFAOYSA-N 0.000 claims 1
- DZFFAHLKOQEHBW-UHFFFAOYSA-N 5-ethyl-3-propan-2-yl-1,2-oxazole-4-carboxylic acid Chemical compound CCC=1ON=C(C(C)C)C=1C(O)=O DZFFAHLKOQEHBW-UHFFFAOYSA-N 0.000 claims 1
- XTIWMXFCHBNILL-UHFFFAOYSA-N 5-iodo-3-methyl-1,2-thiazole-4-carboxylic acid Chemical compound CC1=NSC(I)=C1C(O)=O XTIWMXFCHBNILL-UHFFFAOYSA-N 0.000 claims 1
- RJUBRYYKCHYVEP-UHFFFAOYSA-N 5-methoxy-1,2-dimethylindole-3-carboxylic acid Chemical compound COC1=CC=C2N(C)C(C)=C(C(O)=O)C2=C1 RJUBRYYKCHYVEP-UHFFFAOYSA-N 0.000 claims 1
- YIJZWIPPIODAAK-UHFFFAOYSA-N 5-methoxy-1,3-dimethylindole-2-carboxylic acid Chemical compound COC1=CC=C2N(C)C(C(O)=O)=C(C)C2=C1 YIJZWIPPIODAAK-UHFFFAOYSA-N 0.000 claims 1
- OIWNDJQQIMISPC-UHFFFAOYSA-N 5-methyl-1,3-thiazole-4-carboxylic acid Chemical compound CC=1SC=NC=1C(O)=O OIWNDJQQIMISPC-UHFFFAOYSA-N 0.000 claims 1
- PENHKTNQUJMHIR-UHFFFAOYSA-N 5-methyl-3-phenyl-1,2-oxazole-4-carboxylic acid Chemical compound OC(=O)C1=C(C)ON=C1C1=CC=CC=C1 PENHKTNQUJMHIR-UHFFFAOYSA-N 0.000 claims 1
- TYGXTLZIBFXYQP-UHFFFAOYSA-N 5-methyl-3-propan-2-yl-1,2-oxazole-4-carboxylic acid Chemical compound CC(C)C1=NOC(C)=C1C(O)=O TYGXTLZIBFXYQP-UHFFFAOYSA-N 0.000 claims 1
- XJYOBHXWBRKOQO-UHFFFAOYSA-N 5-phenyl-1,2-oxazole-3-carboxylic acid Chemical compound O1N=C(C(=O)O)C=C1C1=CC=CC=C1 XJYOBHXWBRKOQO-UHFFFAOYSA-N 0.000 claims 1
- RUKDIKJSGDVSIF-UHFFFAOYSA-N 5-phenyl-1,3-oxazole-4-carboxylic acid Chemical compound N1=COC(C=2C=CC=CC=2)=C1C(=O)O RUKDIKJSGDVSIF-UHFFFAOYSA-N 0.000 claims 1
- SFSXXMXHJOSBAZ-UHFFFAOYSA-N 5-tert-butyl-2-methylpyrazole-3-carboxylic acid Chemical compound CN1N=C(C(C)(C)C)C=C1C(O)=O SFSXXMXHJOSBAZ-UHFFFAOYSA-N 0.000 claims 1
- VSQMBZXCDDTZAF-UHFFFAOYSA-N 6-methylimidazo[2,1-b][1,3]thiazole-5-carboxylic acid Chemical compound S1C=CN2C(C(O)=O)=C(C)N=C21 VSQMBZXCDDTZAF-UHFFFAOYSA-N 0.000 claims 1
- 208000029966 Hutchinson Melanotic Freckle Diseases 0.000 claims 1
- 206010020649 Hyperkeratosis Diseases 0.000 claims 1
- QOADIMYPCZMZSG-UHFFFAOYSA-N Isodehydracetic acid Chemical compound CC1=CC(=O)OC(C)=C1C(O)=O QOADIMYPCZMZSG-UHFFFAOYSA-N 0.000 claims 1
- 208000001126 Keratosis Diseases 0.000 claims 1
- YLYXGUOCICLSGX-UHFFFAOYSA-N O=C1CCN(C2=CC=CC=C12)C(=O)O Chemical compound O=C1CCN(C2=CC=CC=C12)C(=O)O YLYXGUOCICLSGX-UHFFFAOYSA-N 0.000 claims 1
- 206010039792 Seborrhoea Diseases 0.000 claims 1
- 206010039796 Seborrhoeic keratosis Diseases 0.000 claims 1
- 239000013543 active substance Substances 0.000 claims 1
- 208000025009 anogenital human papillomavirus infection Diseases 0.000 claims 1
- 201000004201 anogenital venereal wart Diseases 0.000 claims 1
- MEOZFUYXLCDYGA-UHFFFAOYSA-N azepane-1-carboxylic acid Chemical compound OC(=O)N1CCCCCC1 MEOZFUYXLCDYGA-UHFFFAOYSA-N 0.000 claims 1
- 125000003725 azepanyl group Chemical group 0.000 claims 1
- 125000004622 benzoxazinyl group Chemical group O1NC(=CC2=C1C=CC=C2)* 0.000 claims 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims 1
- 230000015572 biosynthetic process Effects 0.000 claims 1
- 229910052794 bromium Inorganic materials 0.000 claims 1
- ZKOMQFDQFTVPBZ-UHFFFAOYSA-N cinnoline-4-carboxylic acid Chemical compound C1=CC=C2C(C(=O)O)=CN=NC2=C1 ZKOMQFDQFTVPBZ-UHFFFAOYSA-N 0.000 claims 1
- 125000005390 cinnolyl group Chemical group N1=NC(=CC2=CC=CC=C12)* 0.000 claims 1
- GKIRPKYJQBWNGO-OCEACIFDSA-N clomifene Chemical compound C1=CC(OCCN(CC)CC)=CC=C1C(\C=1C=CC=CC=1)=C(\Cl)C1=CC=CC=C1 GKIRPKYJQBWNGO-OCEACIFDSA-N 0.000 claims 1
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 claims 1
- 125000004186 cyclopropylmethyl group Chemical group [H]C([H])(*)C1([H])C([H])([H])C1([H])[H] 0.000 claims 1
- 125000005044 dihydroquinolinyl group Chemical group N1(CC=CC2=CC=CC=C12)* 0.000 claims 1
- 125000005056 dihydrothiazolyl group Chemical group S1C(NC=C1)* 0.000 claims 1
- 229940079593 drug Drugs 0.000 claims 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims 1
- 229910052731 fluorine Inorganic materials 0.000 claims 1
- 125000002541 furyl group Chemical group 0.000 claims 1
- 125000005842 heteroatom Chemical group 0.000 claims 1
- 150000004677 hydrates Chemical class 0.000 claims 1
- 125000002883 imidazolyl group Chemical group 0.000 claims 1
- 125000004857 imidazopyridinyl group Chemical group N1C(=NC2=C1C=CC=N2)* 0.000 claims 1
- 125000003453 indazolyl group Chemical group N1N=C(C2=C1C=CC=C2)* 0.000 claims 1
- 125000003387 indolinyl group Chemical group N1(CCC2=CC=CC=C12)* 0.000 claims 1
- 125000001041 indolyl group Chemical group 0.000 claims 1
- 125000004594 isoindolinyl group Chemical group C1(NCC2=CC=CC=C12)* 0.000 claims 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 claims 1
- XAAKCCMYRKZRAK-UHFFFAOYSA-M isoquinoline-1-carboxylate Chemical compound C1=CC=C2C(C(=O)[O-])=NC=CC2=C1 XAAKCCMYRKZRAK-UHFFFAOYSA-M 0.000 claims 1
- 125000005956 isoquinolyl group Chemical group 0.000 claims 1
- 125000001786 isothiazolyl group Chemical group 0.000 claims 1
- 125000000842 isoxazolyl group Chemical group 0.000 claims 1
- 230000003211 malignant effect Effects 0.000 claims 1
- 125000004170 methylsulfonyl group Chemical group [H]C([H])([H])S(*)(=O)=O 0.000 claims 1
- STUHQDIOZQUPGP-UHFFFAOYSA-N morpholin-4-ium-4-carboxylate Chemical compound OC(=O)N1CCOCC1 STUHQDIOZQUPGP-UHFFFAOYSA-N 0.000 claims 1
- 125000002757 morpholinyl group Chemical group 0.000 claims 1
- 230000009826 neoplastic cell growth Effects 0.000 claims 1
- 125000001715 oxadiazolyl group Chemical group 0.000 claims 1
- 125000002971 oxazolyl group Chemical group 0.000 claims 1
- 125000004043 oxo group Chemical group O=* 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
- DNUTZBZXLPWRJG-UHFFFAOYSA-M piperidine-1-carboxylate Chemical compound [O-]C(=O)N1CCCCC1 DNUTZBZXLPWRJG-UHFFFAOYSA-M 0.000 claims 1
- 125000003386 piperidinyl group Chemical group 0.000 claims 1
- 125000005936 piperidyl group Chemical group 0.000 claims 1
- 230000002265 prevention Effects 0.000 claims 1
- 125000003226 pyrazolyl group Chemical group 0.000 claims 1
- 125000004076 pyridyl group Chemical group 0.000 claims 1
- 125000000714 pyrimidinyl group Chemical group 0.000 claims 1
- NYCVCXMSZNOGDH-UHFFFAOYSA-N pyrrolidine-1-carboxylic acid Chemical compound OC(=O)N1CCCC1 NYCVCXMSZNOGDH-UHFFFAOYSA-N 0.000 claims 1
- 125000000719 pyrrolidinyl group Chemical group 0.000 claims 1
- 125000000168 pyrrolyl group Chemical group 0.000 claims 1
- VQMSRUREDGBWKT-UHFFFAOYSA-N quinoline-4-carboxylic acid Chemical compound C1=CC=C2C(C(=O)O)=CC=NC2=C1 VQMSRUREDGBWKT-UHFFFAOYSA-N 0.000 claims 1
- 125000005493 quinolyl group Chemical group 0.000 claims 1
- 125000001567 quinoxalinyl group Chemical group N1=C(C=NC2=CC=CC=C12)* 0.000 claims 1
- 201000003385 seborrheic keratosis Diseases 0.000 claims 1
- 239000002904 solvent Substances 0.000 claims 1
- 125000005931 tert-butyloxycarbonyl group Chemical group [H]C([H])([H])C(OC(*)=O)(C([H])([H])[H])C([H])([H])[H] 0.000 claims 1
- 125000006173 tetrahydropyranylmethyl group Chemical group 0.000 claims 1
- 125000001544 thienyl group Chemical group 0.000 claims 1
- 238000011200 topical administration Methods 0.000 claims 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 1
- BLZLCWBWUXIGQV-UHFFFAOYSA-N 3,5-diethyl-1,2-oxazole-4-carboxylic acid Chemical compound CCC1=NOC(CC)=C1C(O)=O BLZLCWBWUXIGQV-UHFFFAOYSA-N 0.000 description 4
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 description 3
- 125000000882 C2-C6 alkenyl group Chemical group 0.000 description 3
- 125000003601 C2-C6 alkynyl group Chemical group 0.000 description 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 3
- 125000002877 alkyl aryl group Chemical group 0.000 description 3
- 125000005119 alkyl cycloalkyl group Chemical group 0.000 description 3
- 125000005213 alkyl heteroaryl group Chemical group 0.000 description 3
- 125000000392 cycloalkenyl group Chemical group 0.000 description 3
- 125000001316 cycloalkyl alkyl group Chemical group 0.000 description 3
- 125000004446 heteroarylalkyl group Chemical group 0.000 description 3
- 125000000217 alkyl group Chemical group 0.000 description 2
- CTSLXHKWHWQRSH-UHFFFAOYSA-N oxalyl chloride Chemical compound ClC(=O)C(Cl)=O CTSLXHKWHWQRSH-UHFFFAOYSA-N 0.000 description 2
- 229940002612 prodrug Drugs 0.000 description 2
- 239000000651 prodrug Substances 0.000 description 2
- UGQCGHYUOICVJN-UHFFFAOYSA-N 3,5-diethyl-1,2-oxazole-4-carbonyl chloride Chemical class CCC1=NOC(CC)=C1C(Cl)=O UGQCGHYUOICVJN-UHFFFAOYSA-N 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 239000003039 volatile agent Substances 0.000 description 1
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201061426378P | 2010-12-22 | 2010-12-22 | |
| US61/426,378 | 2010-12-22 | ||
| US201161448350P | 2011-03-02 | 2011-03-02 | |
| US61/448,350 | 2011-03-02 | ||
| US201161534055P | 2011-09-13 | 2011-09-13 | |
| US61/534,055 | 2011-09-13 | ||
| PCT/DK2011/000154 WO2012083953A1 (en) | 2010-12-22 | 2011-12-22 | Ingenol-3-acylates iii and ingenol-3-carbamates |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015201428A Division JP6111308B2 (ja) | 2010-12-22 | 2015-10-09 | インゲノール−３−アシラートｉｉｉおよびインゲノール−３−カルバメート |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2014512331A JP2014512331A (ja) | 2014-05-22 |
| JP2014512331A5 true JP2014512331A5 (enExample) | 2015-12-03 |
| JP5845283B2 JP5845283B2 (ja) | 2016-01-20 |
Family
ID=45491187
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013545050A Expired - Fee Related JP5845283B2 (ja) | 2010-12-22 | 2011-12-22 | インゲノール−３−アシラートｉｉｉおよびインゲノール−３−カルバメート |
| JP2015201428A Expired - Fee Related JP6111308B2 (ja) | 2010-12-22 | 2015-10-09 | インゲノール−３−アシラートｉｉｉおよびインゲノール−３−カルバメート |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015201428A Expired - Fee Related JP6111308B2 (ja) | 2010-12-22 | 2015-10-09 | インゲノール−３−アシラートｉｉｉおよびインゲノール−３−カルバメート |
Country Status (18)
| Country | Link |
|---|---|
| US (3) | US9102687B2 (enExample) |
| EP (1) | EP2655323B1 (enExample) |
| JP (2) | JP5845283B2 (enExample) |
| KR (1) | KR20140010372A (enExample) |
| CN (2) | CN104529827B (enExample) |
| AU (2) | AU2011348637B2 (enExample) |
| BR (1) | BR112013015855A2 (enExample) |
| CA (1) | CA2822310A1 (enExample) |
| ES (1) | ES2659739T3 (enExample) |
| IL (2) | IL226904A (enExample) |
| MX (1) | MX339823B (enExample) |
| MY (1) | MY160501A (enExample) |
| NZ (2) | NZ612446A (enExample) |
| RU (1) | RU2572549C2 (enExample) |
| SG (2) | SG191196A1 (enExample) |
| TW (2) | TWI548616B (enExample) |
| WO (1) | WO2012083953A1 (enExample) |
| ZA (1) | ZA201304281B (enExample) |
Families Citing this family (49)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2012088266A2 (en) | 2010-12-22 | 2012-06-28 | Incyte Corporation | Substituted imidazopyridazines and benzimidazoles as inhibitors of fgfr3 |
| HUE042374T2 (hu) | 2012-06-13 | 2019-06-28 | Incyte Holdings Corp | Szubsztituált triciklusos vegyületek mint FGFR inhibitorok |
| PT2864290T (pt) * | 2012-06-26 | 2017-09-19 | Leo Laboratories Ltd | 3-o-heteroaril-ingenol |
| US9388185B2 (en) | 2012-08-10 | 2016-07-12 | Incyte Holdings Corporation | Substituted pyrrolo[2,3-b]pyrazines as FGFR inhibitors |
| BR102012028120B8 (pt) * | 2012-11-01 | 2022-08-02 | Amazonia Fitomedicamentos Ltda | Uso de um ou mais derivados de ingenol, composição farmacêutica e medicamento |
| US9266892B2 (en) | 2012-12-19 | 2016-02-23 | Incyte Holdings Corporation | Fused pyrazoles as FGFR inhibitors |
| HUE036571T2 (hu) | 2013-04-19 | 2018-07-30 | Incyte Holdings Corp | Biciklusos heterociklusok mint FGFR inhibitorok |
| US9720137B2 (en) | 2013-09-26 | 2017-08-01 | Mitsui Chemicals, Inc. | Eyewear material, eyewear frame, and eyewear |
| US9713608B2 (en) * | 2013-10-25 | 2017-07-25 | Leo Laboratories Limited | Method for topically treating actinic keratosis on the trunk (except chest) or extremities with ingenol 3-(3,5-diethylisoxazole-4-carboxylate) |
| US10851105B2 (en) | 2014-10-22 | 2020-12-01 | Incyte Corporation | Bicyclic heterocycles as FGFR4 inhibitors |
| EP3223813A1 (en) * | 2014-11-28 | 2017-10-04 | Leo Laboratories Limited | A method for topically treating actinic keratosis on the scalp with ingenol 3-(3,5-diethylisoxazole-4-carboxylate) |
| WO2016083562A1 (en) * | 2014-11-28 | 2016-06-02 | Leo Laboratories Limited | A method for topically treating actinic keratosis on the full face or 250 cm2 on the chest with ingenol 3-(3,5-diethylisoxazole-4-carboxylate) |
| US20170258769A1 (en) * | 2014-11-28 | 2017-09-14 | Leo Laboratories Limited | A Method for Topically Treating Actinic Keratosis on the Trunk (except chest) and Extremities with Ingenol 3-(3,5-diethylisoxazole-4-carboxylate) |
| MX388991B (es) | 2015-02-20 | 2025-03-20 | Incyte Corp | Heterociclos biciclicos como inhibidores de receptores del factor de crecimiento fibroblastico (fgfr) |
| US9580423B2 (en) | 2015-02-20 | 2017-02-28 | Incyte Corporation | Bicyclic heterocycles as FGFR4 inhibitors |
| MA41551A (fr) | 2015-02-20 | 2017-12-26 | Incyte Corp | Hétérocycles bicycliques utilisés en tant qu'inhibiteurs de fgfr4 |
| WO2016173651A1 (en) * | 2015-04-29 | 2016-11-03 | Leo Laboratories Limited | Formulations comprising ingenol 3-(3,5-diethylisoxazole-4-carboxylate) |
| WO2016191837A1 (pt) * | 2015-06-03 | 2016-12-08 | Amazônia Fitomedicamentos Ltda. | Método de preparação de ingenol-3-hexanoato, método de preparação de 3-etinil-3-hidroxi-4.7.7-trimetilbiciclo[4.1.0]heptano-2-carbaldeído e método de preparação do composto 2,2-dimetil-4-etinil-5-trifenilfosforanilideno-1,3-dioxano |
| WO2016191835A1 (pt) * | 2015-06-03 | 2016-12-08 | Amazônia Fitomedicamentos Ltda. | Método de preparação de ingenol-5,20-acetonida, método de preparação de 3-etinil-3-hidroxi-4.7.7-trimetilbiciclo[4.1.0] heptano-2-carbaldeído, método de preparação do composto 2,2-dimetil-4-etinil-5 -trifenilfosforanilideno-1,3-dioxano e composto intermediário |
| WO2016191836A1 (pt) * | 2015-06-03 | 2016-12-08 | Amazônia Fitomedicamentos Ltda. | Método de preparação de ingenol-3-dodecanoato, método de preparação de 3-etinil-3-hidroxi-4.7.7-trimetilbiciclo[4.1.0]heptano-2-carbaldeído e método de preparação de 2,2-dimetil-4-etinil-5-trifenilfosforanilideno-1,3-dioxano |
| US12502369B2 (en) | 2015-11-11 | 2025-12-23 | K-Gen, Inc. | Methods of cancer treatment |
| WO2017089301A1 (en) * | 2015-11-27 | 2017-06-01 | Leo Laboratories Limited | 3-triazolo-3-deoxy-ingenols |
| WO2017089300A1 (en) * | 2015-11-27 | 2017-06-01 | Leo Laboratories Limited | 3-alkylamido-3-deoxy-ingenols |
| WO2017108927A1 (en) * | 2015-12-22 | 2017-06-29 | Leo Laboratories Limited | Process for preparation of ingenol 3-(3.5-diethylisoxazole-4-carboxylate) |
| WO2017130156A1 (en) | 2016-01-27 | 2017-08-03 | Glaxosmithkline Intellectual Property (No.2) Limited | Ingenol analogs, pharmaceutical compositions and methods of use thereof |
| WO2017156350A1 (en) | 2016-03-09 | 2017-09-14 | K-Gen, Inc. | Methods of cancer treatment |
| CN106619600B (zh) * | 2016-03-28 | 2019-10-18 | 中国科学院遗传与发育生物学研究所 | 巨大戟醇及其衍生物在增强溶酶体生成中的应用 |
| CN106083771A (zh) * | 2016-06-13 | 2016-11-09 | 崔坤峰 | 卡比多巴的药物组合物及其治疗肝癌的医药用途 |
| WO2018046337A1 (en) | 2016-09-06 | 2018-03-15 | Indena S.P.A. | Solid forms of ingenol 3-(3,5-diethylisoxazole-4-carboxylate) and method for preparing the same |
| US11370743B2 (en) | 2017-05-12 | 2022-06-28 | The Board Of Trustees Of The Leland Stanford Junior University | Prodrug derivatives of protein kinase C modulators |
| AR111960A1 (es) | 2017-05-26 | 2019-09-04 | Incyte Corp | Formas cristalinas de un inhibidor de fgfr y procesos para su preparación |
| EP3788047B1 (en) | 2018-05-04 | 2024-09-04 | Incyte Corporation | Solid forms of an fgfr inhibitor and processes for preparing the same |
| BR112020022373A2 (pt) | 2018-05-04 | 2021-02-02 | Incyte Corporation | sais de um inibidor de fgfr |
| US11628162B2 (en) | 2019-03-08 | 2023-04-18 | Incyte Corporation | Methods of treating cancer with an FGFR inhibitor |
| US11591329B2 (en) | 2019-07-09 | 2023-02-28 | Incyte Corporation | Bicyclic heterocycles as FGFR inhibitors |
| WO2021067374A1 (en) | 2019-10-01 | 2021-04-08 | Incyte Corporation | Bicyclic heterocycles as fgfr inhibitors |
| KR20220100879A (ko) | 2019-10-14 | 2022-07-18 | 인사이트 코포레이션 | Fgfr 저해제로서의 이환식 헤테로사이클 |
| US11566028B2 (en) | 2019-10-16 | 2023-01-31 | Incyte Corporation | Bicyclic heterocycles as FGFR inhibitors |
| WO2021113479A1 (en) | 2019-12-04 | 2021-06-10 | Incyte Corporation | Tricyclic heterocycles as fgfr inhibitors |
| KR20220131900A (ko) | 2019-12-04 | 2022-09-29 | 인사이트 코포레이션 | Fgfr 억제제의 유도체 |
| US12012409B2 (en) | 2020-01-15 | 2024-06-18 | Incyte Corporation | Bicyclic heterocycles as FGFR inhibitors |
| CN112125918B (zh) * | 2020-07-16 | 2021-10-01 | 中国科学院南海海洋研究所 | 芳香聚酮类化合物Talaromyoxaones A和B及其制备方法和应用 |
| CN113150162A (zh) * | 2021-03-11 | 2021-07-23 | 广东康辉集团有限公司 | 一种氨基甲酸酯类农药的抗体的制备方法和应用 |
| WO2022221170A1 (en) | 2021-04-12 | 2022-10-20 | Incyte Corporation | Combination therapy comprising an fgfr inhibitor and a nectin-4 targeting agent |
| TW202313611A (zh) | 2021-06-09 | 2023-04-01 | 美商英塞特公司 | 作為ｆｇｆｒ抑制劑之三環雜環 |
| EP4352060A1 (en) | 2021-06-09 | 2024-04-17 | Incyte Corporation | Tricyclic heterocycles as fgfr inhibitors |
| CN114349707B (zh) * | 2022-01-20 | 2024-01-09 | 中国医学科学院医药生物技术研究所 | 一种n-取代脲类化合物及其制备方法和应用 |
| DE102022131737A1 (de) | 2022-11-30 | 2024-06-06 | Technische Universität München, Körperschaft des öffentlichen Rechts | Pyrrol-Verbindung und Verfahren zur Herstellung einer Pyrrol-Verbindung |
| CN117224480A (zh) * | 2023-08-03 | 2023-12-15 | 复旦大学 | 一种中药甘遂活性单体的自纳米乳系统及其制备方法 |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5955501A (en) * | 1986-06-11 | 1999-09-21 | Procyon Pharmaceuticals, Inc. | Protein kinase C modulators O |
| US5891906A (en) | 1986-06-11 | 1999-04-06 | Procyon Pharmaceuticals, Inc. | Polyacetate-derived phorboids having anti-inflammatory and other uses |
| US5145842A (en) * | 1986-06-11 | 1992-09-08 | Alder Research Center Limited Partnership | Protein kinase c. modulators. d. |
| IL82811A0 (en) | 1986-06-11 | 1987-12-20 | Alder Res Center Corp | Anti-inflammatory compositions containing methanol derivatives and novel compounds contained therein |
| US5891870A (en) | 1986-06-11 | 1999-04-06 | Procyon Pharmaceuticals, Inc. | Protein kinase C modulators Q |
| DE69131667D1 (de) | 1990-07-30 | 1999-11-04 | Procyon Pharm Inc | Proteinkinase-c-modulatoren mit entzündungshemmender und antiviraler aktivität |
| JPH07165600A (ja) | 1993-10-18 | 1995-06-27 | Souyaku Gijutsu Kenkyusho:Kk | 抗ウイルス剤 |
| JPH08245505A (ja) * | 1994-09-09 | 1996-09-24 | Tosoh Corp | ジテルペン誘導体、その製造法及びそれを有効成分として含有する抗腫瘍剤 |
| JPH08245379A (ja) * | 1995-01-12 | 1996-09-24 | Soyaku Gijutsu Kenkyusho:Kk | 抗ウイルス剤 |
| JPH08268961A (ja) * | 1996-02-28 | 1996-10-15 | Procyon Pharmaceut Inc | 抗炎症組成物 |
| AUPO864097A0 (en) * | 1997-08-19 | 1997-09-11 | Peplin Pty Ltd | Anti-cancer compounds |
| AUPQ801700A0 (en) * | 2000-06-07 | 2000-06-29 | Peplin Research Pty Ltd | Enzyme and viral activation |
| BRPI0418305A (pt) * | 2004-01-01 | 2007-05-02 | Panacea Biotec Ltd | composições farmacêuticas compreendendo um extrato de euphorbia prostrata |
| WO2006116897A1 (fr) * | 2005-04-30 | 2006-11-09 | Nihon University | Diterpenes provenant de euphorbia kansui et leur utilisation |
| EP1924548B1 (en) * | 2005-07-13 | 2018-03-28 | Salvia Sciences, Inc. | Ester prodrugs of prostratin and related phorbol compounds |
| NZ568168A (en) * | 2005-11-25 | 2012-06-29 | Leo Lab Ltd | Methods for wound healing using ingenol compounds |
| GB0525680D0 (en) | 2005-12-16 | 2006-01-25 | Peplin Ltd | Therapeutic compositions |
| AU2006201661A1 (en) * | 2006-04-20 | 2007-11-08 | Peplin Research Pty Ltd | A method of diagnosis and treatment |
| CA2541903A1 (en) * | 2006-04-20 | 2007-10-20 | Peplin Research Pty. Ltd. | A method of diagnosis and treatment |
| BRPI0810806A2 (pt) | 2007-04-30 | 2014-10-29 | Peplin Research Pty Ltd | Método para tratar uma lesão cutânea em um indivíduo |
| EP2146780A1 (en) | 2007-05-11 | 2010-01-27 | Sonneborn Inc. | Petrolatums having silicone-like properties |
| AU2010200429A1 (en) * | 2009-02-05 | 2010-08-19 | Ecobiotics Ltd | Method of reducing or preventing blowfly strike |
-
2011
- 2011-12-22 ES ES11808566.1T patent/ES2659739T3/es active Active
- 2011-12-22 NZ NZ612446A patent/NZ612446A/en not_active IP Right Cessation
- 2011-12-22 CN CN201410662664.4A patent/CN104529827B/zh not_active Expired - Fee Related
- 2011-12-22 SG SG2013046438A patent/SG191196A1/en unknown
- 2011-12-22 CA CA2822310A patent/CA2822310A1/en not_active Abandoned
- 2011-12-22 SG SG10201510566UA patent/SG10201510566UA/en unknown
- 2011-12-22 MY MYPI2013002354A patent/MY160501A/en unknown
- 2011-12-22 AU AU2011348637A patent/AU2011348637B2/en not_active Ceased
- 2011-12-22 CN CN201180068162.3A patent/CN103402977B/zh not_active Expired - Fee Related
- 2011-12-22 EP EP11808566.1A patent/EP2655323B1/en not_active Not-in-force
- 2011-12-22 TW TW100148201A patent/TWI548616B/zh active
- 2011-12-22 NZ NZ710133A patent/NZ710133A/en not_active IP Right Cessation
- 2011-12-22 MX MX2013006995A patent/MX339823B/es active IP Right Grant
- 2011-12-22 US US13/996,989 patent/US9102687B2/en not_active Expired - Fee Related
- 2011-12-22 WO PCT/DK2011/000154 patent/WO2012083953A1/en not_active Ceased
- 2011-12-22 KR KR1020137019271A patent/KR20140010372A/ko not_active Ceased
- 2011-12-22 TW TW105107665A patent/TWI591047B/zh not_active IP Right Cessation
- 2011-12-22 RU RU2013133874/04A patent/RU2572549C2/ru not_active IP Right Cessation
- 2011-12-22 BR BR112013015855A patent/BR112013015855A2/pt not_active IP Right Cessation
- 2011-12-22 JP JP2013545050A patent/JP5845283B2/ja not_active Expired - Fee Related
-
2013
- 2013-06-11 ZA ZA2013/04281A patent/ZA201304281B/en unknown
- 2013-06-13 IL IL226904A patent/IL226904A/en active IP Right Grant
-
2015
- 2015-04-21 IL IL238396A patent/IL238396A0/en unknown
- 2015-06-24 US US14/748,925 patent/US9708286B2/en not_active Expired - Fee Related
- 2015-08-07 AU AU2015210441A patent/AU2015210441B2/en not_active Ceased
- 2015-10-09 JP JP2015201428A patent/JP6111308B2/ja not_active Expired - Fee Related
-
2017
- 2017-04-14 US US15/488,140 patent/US20170217910A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2014512331A5 (enExample) | ||
| RU2013133874A (ru) | Ингенол-3-ацилаты iii и ингенол-3-карбаматы | |
| CN101679413B (zh) | 3-([1,2,4]三唑[4,3-a]吡啶-7-基)苯甲酰胺衍生物 | |
| US9926285B2 (en) | Allosteric modulators of nicotinic acetylcholine receptors | |
| RU2655380C2 (ru) | Циклоалкилнитрилпиразолопиридоны в качестве ингибиторов янус-киназы | |
| JP2019536785A5 (enExample) | ||
| RU2012126083A (ru) | Производные аминооксазина | |
| JP2006502112A5 (enExample) | ||
| EP2688872A1 (en) | Amidopyrazole inhibitors of interleukin receptor-associated kinases | |
| JP2016523911A5 (enExample) | ||
| JP2006508935A5 (enExample) | ||
| RU2015138964A (ru) | Полициклические модуляторы рецептора эстрогена и их применения | |
| ES2684050T3 (es) | Inhibidores de aldosterona sintasa | |
| AU2014234909A1 (en) | Acyclic cyanoethylpyrazolo pyridones as Janus kinase inhibitors | |
| US11332463B2 (en) | Spiropiperidine allosteric modulators of nicotinic acetylcholine receptors | |
| CA2146018A1 (en) | Dopamine receptor subtype ligands | |
| ES2397305T3 (es) | Derivados de oxadiazol y tiadiazol-oxima de pirrolidina que son antagonistas del receptor oxitocina | |
| US10870630B2 (en) | Substituted bicyclic heteroaryl allosteric modulators of nicotinic acetylcholine receptors | |
| RU2007102226A (ru) | Соединения и композиции в качестве ингибиторов протеинкиназы | |
| US11198687B2 (en) | Heteroaryl allosteric modulators of nicotinic acetylcholine receptors | |
| US11793821B2 (en) | Substituted 6-membered aryl or heteroaryl allosteric modulators of nicotinic acetylcholine receptors | |
| TW201024276A (en) | Spirocyclobutyl piperidine derivatives | |
| JP2024508817A (ja) | Ｂ型肝炎ウイルス感染症の処置および予防のためのベンゾチアゾリルビシクロ［１．１．１］ペンタン誘導体 | |
| BR112018069456B1 (pt) | Composto útil como modulador de a7 nAChR ou um sal farmaceuticamente aceitável do mesmo, sua composição farmacêutica e seu uso | |
| HK40045594A (en) | Spiropiperidine allosteric modulators of nicotinic acetylcholine receptors |